An assessment of the potential use of anionic dextrans as a plasma substitute.
Several problems exist when dextrans are used as plasma substitutes. High molecular weight dextrans can cause red cell aggregation and increased blood viscosity. Low molecular weight dextrans, although shown to improve circulation and promote flow, are removed rather rapidly from the circulation due to high premeation rates across capillary walls. In the present study, a small anionic charge is introduced onto the dextran to make it electrostatically negative. Since capillary walls have been shown to retain negatively charged solutes in preference to neutral solutes, the anionic dextran should retain its effectiveness for longer periods of time compared to similar sized neutral dextran. Studies were done on eight unanaesthetized dogs to compare the relative disappearance rates of dextran and anionic dextran (carboxymethyl dextran) from the circulation. It was shown that anionic dextrans do remain in the circulation over a longer period of time compared to neutral dextrans.
D000818:Animals; D000838:Anions; D002199:Capillary Permeability; D003911:Dextrans / Q000032:analysis / Q000097:blood / Q000627:therapeutic use*; D004285:Dogs; D008657:Metabolic Clearance Rate; D008970:Molecular Weight; D010952:Plasma Substitutes
D000838:Anions; D003911:Dextrans; D010952:Plasma Substitutes